Back to search
FDAFDA · Food and drugs·Recall number D-0033-2018

AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testosterone per pump actuation, 60 metered pump actuations, Rx Only, Marketed by: AbbVie Inc., North Chicago, IL 60064 USA. NDC: 0051-8462-33

Published November 1, 2017 · Recall initiated: September 8, 2017

Summary

FDA records drug Class III recall D-0033-2018, published November 1, 2017 and initiated September 8, 2017. Recalling firm: AbbVie Inc.; Status: Terminated; Reported quantity: 520 pumps; Lot: Lot: 91122, EXP. 01/2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AbbVie Inc.
Distributor
AZ
Lot
Lot: 91122, EXP. 01/2020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testosterone per pump actuation, 60 metered pump actuations, Rx Only, Marketed by: AbbVie Inc., North Chicago, IL 60064 USA. NDC: 0051-8462-33 recalled?

Yes. FDA published recall D-0033-2018 on November 1, 2017. Reported hazard: Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.

What should I do if I have this product?

Voluntary: Firm initiated · Letter